apollo

Online Doctor Consultation & Medicines

Hello,

Select your location

Special offers

  1. Home
  2. VELTIP 2MG INJECTION 2ML

VELTIP 2MG INJECTION 2ML

Manufacturer/Marketer

PFIZER LTD

Composition

BORTEZOMIB-2MG

Consume Type

PARENTERAL

In Stock

Prescription Required
Product Details

About VELTIP 2MG INJECTION 2ML

VELTIP 2MG INJECTION 2ML belongs to a group of anti-cancer medicines used to treat adult patients with multiple myeloma and mantle cell lymphoma who have received at least one prior therapy. Multiple myeloma, also known as myeloma, is a type of bone marrow cancer it affects several areas of the body, such as the spine, skull, pelvis, and ribs. Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma (NHL). It develops when B-cells (also called B-lymphocytes) become abnormal. B-cells are white blood cells that fight infection.

VELTIP 2MG INJECTION 2ML contains 'Bortezomibx' that works by interfering with how proteasomes work, which may cause cancer cells to die and may stop cancer from growing and eventually kills them.

VELTIP 2MG INJECTION 2ML is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously or SC). VELTIP 2MG INJECTION 2ML must not be administered into your spinal fluid (intrathecally). You may experience nausea, diarrhoea, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), peripheral neuropathy (nerves malfunction), fatigue, neuralgia, anaemia, leukopenia, constipation, vomiting, lymphopenia, rash, pyrexia, and anorexia. Most of these side effects of VELTIP 2MG INJECTION 2ML do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

To treat your condition effectually, continue taking VELTIP 2MG INJECTION 2ML for as long as your doctor has prescribed. Do not stop the VELTIP 2MG INJECTION 2ML midway. Talk to your doctor before taking VELTIP 2MG INJECTION 2ML if you have allergies or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Avoid taking VELTIP 2MG INJECTION 2ML if you are pregnant or breastfeeding because this VELTIP 2MG INJECTION 2ML can cause harmful effects on the unborn baby. Both women and men using this VELTIP 2MG INJECTION 2ML should use birth control to avoid pregnancy.

Uses of VELTIP 2MG INJECTION 2ML

Multiple myeloma and Mantle cell lymphoma.

Medicinal Benefits

VELTIP 2MG INJECTION 2ML contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells. VELTIP 2MG INJECTION 2ML is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in 18 years or older patients. It can be used alone or together with other medicines.

Directions for Use

VELTIP 2MG INJECTION 2ML will be administered by a qualified healthcare professional. Kindly do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of VELTIP 2MG INJECTION 2ML

  • Nausea
  • Diarrhoea
  • Thrombocytopenia (low blood platelet count)
  • Neutropenia (too few neutrophils)
  • Peripheral neuropathy (nerves malfunction)
  • Fatigue (overtired)
  • Neuralgia (pain in the head or face)
  • Muscle pain, bone pain
  • Anaemia (low red blood cell Count)
  • Leukopenia (Low White Blood Cell Count)
  • High blood pressure
  • Constipation
  • Dehydration
  • Vomiting
  • Loss of appetite
  • Lymphopenia (Low lymphocytes Count)
  • Rash
  • Pyrexia (raised body temperature)
  • Anorexia (lack or loss of appetite for food)
  • Infections, including pneumonia, respiratory infections, bronchitis, fungal infections, coughing with phlegm, flu-like illness

In-Depth Precautions and Warning

Drug Warnings

To treat your condition effectually, continue taking VELTIP 2MG INJECTION 2ML for as long as your doctor has prescribed. Do not stop the VELTIP 2MG INJECTION 2ML midway. Talk to your doctor before taking VELTIP 2MG INJECTION 2ML if you have allergies or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. And also, inform your doctor if you have diabetes because this medicine can affect your blood glucose levels. Your doctor may require close monitoring of your blood glucose levels and change your diabetes medicine dose while being treated with VELTIP 2MG INJECTION 2ML. Avoid taking VELTIP 2MG INJECTION 2ML if you are pregnant because this VELTIP 2MG INJECTION 2ML can cause harmful effects on the unborn baby. Both women and men using this VELTIP 2MG INJECTION 2ML should use birth control to avoid pregnancy and for at least six months following treatment. Do not breastfeed during treatment with VELTIP 2MG INJECTION 2ML and four months after your final dose of VELTIP 2MG INJECTION 2ML.

Drug Interactions

Drug-Drug Interactions: VELTIP 2MG INJECTION 2ML interacts with antifungal medication (ketoconazole), HIV medication (ritonavir), antibiotic medication (rifampicin), epilepsy medications (carbamazepine, phenytoin or phenobarbital), depression medication (St. John’s Wort), and oral antidiabetics.

Drug-Food Interactions: No food interaction was found.

Drug-Disease Interactions: Inform your doctor before taking VELTIP 2MG INJECTION 2ML; it requires close monitoring if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), and hepatic disorders.

Drug-Drug Interactions Checker List:

  • KETOCONAZOLE
  • RITONAVIR
  • RIFAMPICIN
  • CARBAMAZEPINE
  • PHENYTOIN
  • PHENOBARBITAL
  • Safety Advice

    • Safety Warning

      Alcohol

      caution

      You are recommended to avoid alcohol consumption while taking VELTIP 2MG INJECTION 2ML. It could lead to avoiding unpleasant side effects.

    • Safety Warning

      Pregnancy

      unsafe

      VELTIP 2MG INJECTION 2ML should not be used during pregnancy because it causes harm to the fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking VELTIP 2MG INJECTION 2ML and at least six months afterwards. Please discuss with your doctor any concerns regarding this.

    • Safety Warning

      Breast Feeding

      unsafe

      VELTIP 2MG INJECTION 2ML should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers.

    • Safety Warning

      Driving

      caution

      VELTIP 2MG INJECTION 2ML may affect your reactions and your ability to drive. Possible side effects of chemotherapy with VELTIP 2MG INJECTION 2ML may occur, such as nausea and vomiting. If you are affected by these side effects, you should not drive and/or operate machines that require you to be alert.

    • Safety Warning

      Liver

      caution

      If you have a history or evidence of liver-related diseases, inform the doctor before prescribing the VELTIP 2MG INJECTION 2ML. Your doctor will weigh the benefits and potential risks before prescribing them.

    • Safety Warning

      Kidney

      caution

      If you have a history or evidence of kidney-related diseases, inform the doctor before prescribing the VELTIP 2MG INJECTION 2ML. Your doctor will weigh the benefits and potential risks before prescribing them.

    • Safety Warning

      Children

      unsafe

      VELTIP 2MG INJECTION 2ML should not be used by children below 18 years of age, as efficacy and safety have not been established.

    Habit Forming

    No

    Diet & Lifestyle Advise

    • Eat a healthy diet and exercise regularly to maintain proper weight.
    • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs in your diet.
    • Get optimal sleep, and rest well.
    • Performing yoga may also help in improving both physical and mental health.
    • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
    • De-stress yourself by meditating, reading books, taking a warm bubble bath, or listening to soothing music.
    • Avoid smoking and alcohol consumption.
    • Avoid fast, fried, processed meats, refined carbs, and added sugars.

    Special Advise

    • VELTIP 2MG INJECTION 2ML should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking VELTIP 2MG INJECTION 2ML.
    • Your doctor may get routine blood tests done to monitor your liver function, electrolyte levels, blood cell count in your blood.
    • Avoid unnecessary or prolonged exposure to sunlight and UV light (such as tanning booths) and wear protective clothing, sunglasses, and sunscreen. VELTIP 2MG INJECTION 2ML may make your skin sensitive to sunlight.

    Other Information (VEL0077)

    This item is Not Returnable.

    Expires on or after - Sep-23

    Patients Concern

    Disease/Condition Glossary

    Multiple myeloma, also known as myeloma, is a type of bone marrow cancer it affects several areas of the body, such as the spine, skull, pelvis, and ribs.

    Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma (NHL). It develops when B-cells (also called B-lymphocytes) become abnormal. B-cells are white blood cells that fight infection.

    Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.

    FAQs

    How does VELTIP 2MG INJECTION 2ML work?

    VELTIP 2MG INJECTION 2ML contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells.

    How and who will be eligible to give the VELTIP 2MG INJECTION 2ML?

    VELTIP 2MG INJECTION 2ML is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously, or SC). VELTIP 2MG INJECTION 2ML must not be administered into your spinal fluid (intrathecally).

    Does VELTIP 2MG INJECTION 2ML cause lower white blood cells (neutropenia)?

    Yes, VELTIP 2MG INJECTION 2ML can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.

    I am pregnant, can I take VELTIP 2MG INJECTION 2ML?

    Avoid taking VELTIP 2MG INJECTION 2ML if you are pregnant because VELTIP 2MG INJECTION 2ML can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of VELTIP 2MG INJECTION 2ML.

    Who should not receive VELTIP 2MG INJECTION 2ML?

    Before you receive treatment with VELTIP 2MG INJECTION 2ML, tell your doctor about all of your medical conditions. You should not receive VELTIP 2MG INJECTION 2ML if you are allergic to bortezomib or any contents in VELTIP 2MG INJECTION 2ML.

    Is VELTIP 2MG INJECTION 2ML poisonous?

    If not given an inappropriate dose, VELTIP 2MG INJECTION 2ML can cause toxic effects, although not everyone gets it. So, VELTIP 2MG INJECTION 2ML is prescribed by a doctor experienced in using medications to treat cancer only.

    PRODUCT SUBSTITUTES

    VELTIP 2MG INJECTION 2ML

    Country Of Origin

    India

    Manufacturer/Marketer address

    The Capital, 1802, 18th Floor , Plot No. C-70, ‘G’ Block , Bandra Kurla Complex, Bandra East , Mumbai – 400051.

    Disclaimer

    While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

    (Inclusive of all taxes)

    Provide Delivery Location

    Vial

    1

    2 ml Injection in 1 Vial